NPPA issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (As Film Coated Atorvastatin Tablets IP) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (As Film Coated Clopidogrel Tablets IP) + Aspirin IP 75 mg (As Aspirin Gastro-Resistant Tablets IP) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharma Laboratories Ltd. (Marketer)

Jul 18, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on July 16, 2026, issued a notification regarding the fixation of the retail price of Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (As Film Coated Atorvastatin Tablets IP) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (As Film Coated Clopidogrel Tablets IP) + Aspirin IP 75 mg (As Aspirin Gastro-Resistant Tablets IP) for M/s Akums Drugs & Pharmaceuticals Ltd. (Manufacturer) & M/s Sun Pharma Laboratories Ltd. (Marketer).

It states that the price for Each Hard Gelatin Capsule containing Atorvastatin Calcium IP Eq. to Atorvastatin 10 mg (as film-coated Atorvastatin Tablets IP) + Clopidogrel Bisulphate IP Eq. to Clopidogrel 75 mg (as film-coated Clopidogrel Tablets IP) + Aspirin IP 75 mg (As Aspirin Gastro-Resistant Tablets IP) has been fixed at Rs. 6.37/- excluding GST.

[Notification no. - 19(5245)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT